Skip to main content
SpringerLink
Log in

The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Intravenous administration of N,N-di-n-propyldopamine (DPDA: 50 and 200 μg/kg/min, i. v.) produces hypotensive and bradycardic effects in anaesthetized cats and dogs. These effects were abolished by ganglionic blockade and antagonized by haloperidol or (SR)-sulpiride suggesting a neurogenic mechanism of action, mediated by specific dopamine receptors. The renal blood flow increases to DPDA in dogs were resistent to ganglionic blockade indicating some activity at postsynaptic vascular dopamine receptors. Studies with DPDA in vivo administered via the intravertebral and intravenous routes suggested a peripheral site of action for the hypotensive effects of this compound.

In vitro, in isolated perfused cat spleens prelabeled with 3H-noradrenaline, DPDA (0.01–1 μM) produced a concentration-dependent inhibition of tritium release elicited by nerve stimulation at 1 Hz which was selectively antagonized by 1 μM (SR)-sulpiride implicating presynaptic inhibitory dopamine receptors in the mediation of this effect. In isolated rabbit splenic arteries, contracted by prostaglandin-F2α , dopamine, ADTN (2-amino-6,7-dihydroxytetrahydronaphthalene) and apomorphine produced concentration-dependent relaxations while DPDA exhibited only weak postsynaptic dopamine-like effects.

In vivo DPDA reduced, in a frequency dependent manner, the end organ responses to sympathetic nerve stimulation in the cat nictitating membrane and in the dog renal vascular bed. Both effects were mediated through activation of presynaptic inhibitory dopamine receptors by DPDA.

In conclusion these results suggest a predominantly presynaptic agonist effect for DPDA in vitro and a similarly important action in vivo, mediated mainly via dopamine receptors. Furthermore evidence is presented which suggests that pre- and postsynaptic dopamine receptors may differ in their pharmacological properties and that presynaptic dopamine receptors could be important target receptors in the development of novel antihypertensive drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arbilla S, Langer SZ (1978) Differences between the presynaptic and the postsynaptic α-adrenoceptors in the cat nictitating membrane: effects of metanephrine and tolazoline. Br J Pharmacol 64: 259–264

    Google Scholar 

  • Bell C, Matalanis G (1977) Dopamine-induced depression of adrenergic nerve-mediated contraction of smooth muscle. Br J Pharmacol 61: 291–295

    Google Scholar 

  • Bell C, Conway EL, Lang WJ, Padanyl R (1975) Vascular dopamine receptors in the canine hindlimb. Br J Pharmacol 55: 167–172

    Google Scholar 

  • Bogaert MG, De Schaepdryver AF, Willems JL (1977) Dopamine-induced neurogenic vasodilatation in the intact hindleg of the dog. Br J Pharmacol 59: 283–292

    Google Scholar 

  • Boismare F, Belliard JP, Hacpille L (1975) Effets de la l-dopa (associée ou non à un inhibiteur de la decarboxylase extracérébrale) sur le débit vertébral et fémoral du chien en decubitus et en orthostatisme. J Pharmacol (Paris) 6: 15–24

    Google Scholar 

  • Burn JH, Rand MJ (1958) The depressor action of dopamine and adrenaline. Br J Pharmacol 13: 471–479

    Google Scholar 

  • Cannon JG, Hsu FL, Long JP, Flynn JR, Costall B, Naylor RJ (1978) Preparation and biological actions of some symmetrically N,N-Disubstituted dopamines. J Med Chem 21: 248–249

    Google Scholar 

  • Crooks RJ, Martin GR (1979) An isolated vascular tissue preparation showing a specific relaxant effect of dopamine. Br J Pharmacol 67:474P

  • Dubocovich ML, Langer SZ (1974) Negative feed-back regulation of norepinephrine release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J Physiol (Lond) 237: 505–519

    Google Scholar 

  • Dubocovich ML, Langer SZ (1976) Influence of the frequency of nerve stimulation on the metabolism of 3H-noradrenaline released from the perfused cat spleen: differences observed during and after the period of stimulation. J Pharmacol Exp Ther 198: 83–101

    Google Scholar 

  • Dubocovich ML, Langer SZ (1980) Dopamine and α-adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors. J Pharmacol Exp Ther 212: 144–152

    Google Scholar 

  • Dubocovich ML, Langer SZ, Massingham R (1980) Inhibition of noradrenergic neurotransmission by dipropyldopamine through activation of presynaptic dopamine receptors. Br J Pharmacol 69: 297–298P

    Google Scholar 

  • Eble JN (1964) A proposed mechanism for the depressor effect of dopamine in the anaesthetized dog. J Pharmacol Exp Ther 145: 64–70

    Google Scholar 

  • Enero MA, Langer SZ (1975) Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nicitating membrane. Naunyn-Schmiedeberg's Arch Pharmacol 289: 179–203

    Google Scholar 

  • Farmer JB (1965) Impairment of sympathetic nerve responses by dopa, dopamine and their α-methyl analogues. J Pharm Pharmacol 17: 640–646

    Google Scholar 

  • Fuder H, Muscholl E (1978) The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 305: 109–115

    Google Scholar 

  • Ginos JZ, Kohli JD, Goldberg LI (1978) Cardiovascular actions of N-substituted dopamine analogs in the dog. Fed Proc 37: 683

    Google Scholar 

  • Goldberg LI (1972) Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol Rev 24: 1–29

    Google Scholar 

  • Goldberg LI, Kohli JD, Listinsky JJ (1979) Comparison of peripheral pre- and postsynaptic dopamine receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Advances in biosciences, “Presynaptic Receptors”, Vol 18. Pergamon Press, pp 37–41

  • Hamilton TC (1972) Effects of dopamine on the conductance of perfused vascular beds of the chloralosed cat. Br J Pharmacol 44: 442–450

    Google Scholar 

  • Hope W, McCulloch MW, Rand MJ, Story DF (1978) Modulation of noradrenergic transmission in the rabbit ear artery by dopamine. Br J Pharmacol 64: 527–537

    Google Scholar 

  • Horwitz D, Fox SM, Goldberg LI (1962) Effects of dopamine in man. Circ Res 10: 237–243

    Google Scholar 

  • Ilhan M, Long JP (1975) Inhibition of the sympathetic nervous system by dopamine. Arch Int Pharmacodyn 216: 4–10

    Google Scholar 

  • Kohli JD, Cripe LD (1979) Sulpiride: A weak antagonist of noradrenaline and 5-hydroxytryptamine. Eur J Pharmacol 56: 283–286

    Google Scholar 

  • Kohli JD, Goldberg LI, Volkman PH, Cannon JG (1968) N,N-di-n-propyldopamine: A qualitively different dopamine vascular agonist. J Pharmacol Exp Ther 207: 16–22

    Google Scholar 

  • Kohli JD, Listinsly JL, Goldberg LI (1979) The inhibitory neurogenic effects of N,N-di-n-propyldopamine: A vascular dopamine agonist. In: Imbs JL, Schwartz J (eds). Advances in bioscience: “Peripheral dopaminergic receptors”, Vol 20. Pergamon Press, Oxford pp 249–255

    Google Scholar 

  • Langer SZ (1973) The regulation of transmitter release elicited by nerve stimulation through a presynaptic feedback mechanism. In: Usdin E, Snyder S (eds). Frontiers in Catecholamine Research. Pergamon Press, New York, pp 543–549

    Google Scholar 

  • Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23: 1793–1800

    Google Scholar 

  • Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60: 481–497

    Google Scholar 

  • Langer SZ, Dubocovich ML (1979) Physiological and pharmacological role of the regulation of noradrenaline release by presynaptic dopamine receptors in the peripheral nervous system. In: Imbs JL, Schwartz J (eds). Advances in Biosciences Peripheral Dopaminergic Receptors. Vol 20. Pergamon Press, Oxford, pp 223–245

    Google Scholar 

  • Laubie M, Schmitt H (1978) Inhibitory effects of piribedil on adrenergic neurotransmission. Eur J Pharmacol 52: 99–107

    Google Scholar 

  • Laubie M, Schmitt H, Falg E (1977) Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympatho-inhibitory effect. Eur J Pharmacol 42: 307–310

    Google Scholar 

  • Lefevre-Borg F, Cavero I (in press) Stimulation of peripheral dopamine receptors: A mechanism for novel antihypertensive agents. Clin Science Mol Med

  • Lokhandwala MF, Buckley JP (1977a) Analysis of presynaptic inhibitory actions of various dopamine analogues on sympathetic transmission in mongrel dogs. Life Sci 20: 507–516

    Google Scholar 

  • Lokhandwala MF, Buckley JP (1977b) Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction. Eur J Pharmacol 45: 305–309

    Google Scholar 

  • Lokhandwala MF, Jandhyala BS (1979) The role of the sympathetic nervous system in the vascular actions of dopamine. J Pharmacol Exp Ther 210: 120–126

    Google Scholar 

  • McDonald RH, Goldberg LI (1963) Analysis of the cardiovascular effects of dopamine in the dog. J Pharmacol Exp Ther 140: 60–66

    Google Scholar 

  • McDonald RH, Goldberg LI, McNay JL, Tuttle EP (1964) Effect of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Inv 43: 1116–1124

    Google Scholar 

  • McNay JL, Goldberg LI (1966) Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther 151: 23–31

    Google Scholar 

  • Pendleton RG, Samler, L, Kaiser C, Ridley PT (1978) Studies on renal dopamine receptors with a new agonist. Eur J Pharmacol 51: 19–28

    Google Scholar 

  • Sampson RG, Scroop GC, Louis WJ (1974) Cardiovascular effects of dopamine in the anaesthetized dog. Clin Exp Pharmacol Physiol 1: 3–12

    Google Scholar 

  • Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77: 1–124

    Google Scholar 

  • Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 21: 55–78

    Google Scholar 

  • Setler PE, Pendleton RG, Finlay E (1975) The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs. J Pharmacol Exp Ther 192: 707–712

    Google Scholar 

  • Steinsland OS, Hieble JP (1978) Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms. Science 199: 443–445

    Google Scholar 

  • Volkman PM, Kohli JD, Goldberg LI, Cannon JG, Lee T (1977) Conformational requirements for dopamine-induced vasodilatation. Proc Natl Acad Sci 74: 3602–3606

    Google Scholar 

  • Yen TT, Stamm NB, Clemens JA (1979) Pergolide, a potent dopaminergic antihypertensive. Life Sci 25: 209–216

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology Synthélabo, L.E.R.S. 58, rue de la Glacière, F-75013, Paris, France

    R. Massingham, M. L. Dubocovich & S. Z. Langer

Authors
  1. R. Massingham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. L. Dubocovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Z. Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Massingham, R., Dubocovich, M.L. & Langer, S.Z. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog. Naunyn-Schmiedeberg's Arch. Pharmacol. 314, 17–28 (1980). https://doi.org/10.1007/BF00498427

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00498427

Key words

Search

Navigation